MedPath

Treatment of Diabetic Retinopathy

Not Applicable
Conditions
Health Condition 1: E113- Type 2 diabetes mellitus with ophthalmic complications
Registration Number
CTRI/2023/03/050271
Lead Sponsor
GSVM MEDICAL COLLEGE
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
52
Inclusion Criteria

PATIENTS DIAGNOSED WITH TYPE 2 DIABETES MELLITUS WITH MILD AND MODERATE DIABETIC RETINOPATHY

Exclusion Criteria

PATIENTS NOT WILLING TO PARTICIPATE OR READY FOR FOLLOW UP.

PATIENTS HAVING SEVERE DIABETIC RETINOPATHY,PROLIFERATIVE DIABETIC RETINOPATHY AND DIABETIC MACULAR EDEMA.

PATIENTS WITH UNCONTROLLED DIABETES.

PATIENTS WITH ANY OCULAR INFECTION,RAISED INTRAOCULAR PRESSURE,ANY CORNEAL PATHOLOGY,THINNED SCLERA,SCLERITIS,STAPHYLOMA OR ANY OTHER ANTERIOR SEGMENT PATHOLOGY EXCEPT PSEUDOPHAKIC PATIENTS.

PATIENTS DIAGNOSED OF ANY OTHER RETINAL OR VITREOUS PATHOLOGIES EXCEPT DIABETIC RETINOPATHY.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
IMPROVEMENT IN VISUAL ACUITYTimepoint: 3-6 MONTHS
Secondary Outcome Measures
NameTimeMethod
CATARCTTimepoint: 6 MONTHS- 1 YEAR;CHOROIDAL/RETINAL DETACHMENTTimepoint: 1 DAY;DECREASE IN VISUAL ACUITYTimepoint: 1 DAY- 1YEAR;RAISED INTRAOCULAR PRESSURETimepoint: 1-5 DAYS;VITRITIS/ ENDOPHTHALMITISTimepoint: 15 DAYS
© Copyright 2025. All Rights Reserved by MedPath